Cardiac sodium channel plays a key role in the fast depolarization and maintenance of impulse conduction in cardiomyocytes. Mutations of SCN5A gene can lead to many types of arrhythmias. A 14-year-old boy with familial paternal history of sudden unexpected nocturnal death was admitted to hospital with recurrent syncope. A cardiac channelopathy was suspected and a pathogenic ion channel was searched for mutation identification. The proband manifested sinus node dysfunction, ventricular tachycardia, cardiac conduction disturbance involving atrioventricular node and His bundle. The proband and his mother received whole exome sequencing. A heterozygous in-frame deletion N1380del on exon 23 of SCN5A gene locating in a highly conserved pore residue in domain III (S5-S6) was revealed in the proband. The mutation was assessed in other family members by Sanger sequencing. The proband's living uncle and two sisters were asymptomatic mutation carriers with different degrees of cardiac conduction disturbance. Functional analysis was conducted using whole-cell patch clamping in HEK293T cells transfected with wild-type or mutant channels. The HEK293T cells transfected with plasmid pcDNA3.1-N1380del-SCN5A had no detectable sodium current. Overall, N1380del mutation of SCN5A gene leads to loss of function of sodium channel. N1380del is a pathogenetic mutation which can cause cardiac conduction defect and ventricular tachycardia.
Introduction
Cardiac channelopathies, including Brugada syndrome (BrS), long QT syndrome (LQTS), short QT syndrome, progressive cardiac conduction defect (PCCD), congenital sick sinus syndrome, and catecholaminergic polymorphic ventricular tachycardia, are caused by gene mutations or disturbed function of ion channels or their regulators. The concept of channelopathies therefore is not restricted to genetic disorders; notably, changes in the expression or post-translational modification of ion channels underlie the fatal arrhythmias associated with heart failure [1, 2] .
The α subunit of human voltage-gated sodium channel Type 5 (Na v 1.5) encoded by the SCN5A gene plays a key role in the fast depolarization and maintenance of impulse conduction in cardiomyocytes. In human heart, SCN5A is highly expressed in cardiomyocytes and conductive tissue, while the expression in sinoatrial and atrioventricular nodes is relatively low [3] . Since the first mutation of SCN5A associated with long QT syndrome Type 3 (LQTS3) was identified in 1995 [4] , many mutations have been discovered. Moreover, dysfunction of Na v 1.5 is recognized to be associated with BrS Type 1 [5] , PCCD [6] , sick sinus syndrome [7, 8] , and overlaps of these presentations [9] .
In the present study, a 14-year-old boy with familial paternal history of sudden unexpected nocturnal death was admitted with recurrent syncope. A cardiac channelopathy was suspected and a pathogenic ion channel was searched for mutation identification. Finally, a heterozygous in-frame deletion on exon 23 of SCN5A gene was identified and functional analysis was carried out using whole-cell patch clamping.
Materials and Methods

Patients
The proband and his family members who participated in the study provided written informed consent before genetic and clinical investigations, and the study complied with the Declaration of Helsinki and local ethics committees. The proband underwent clinical evaluations, including physical examinations, 12-lead electrocardiography (ECG), echocardiography, chest X-ray, cardiac magnetic resonance imaging (MRI), electrophysiological studies, and endomyocardial biopsy at Zhongshan Hospital, Fudan University (Shanghai China). Other family members were evaluated by 12-lead ECG and echocardiography in local hospitals.
Exome sequencing
Genomic deoxyribonucleic acid (DNA) was isolated from leukocytes according to standard procedures. Whole exome sequencing of the proband and his mother was performed on Illumina Hiseq 2500 platform (San Diego, USA). Exome sequences were prepared using the Agilent SureSelect Human All Exon kit (Santa Clara, USA) and Illumina TruSeq Rapid PE Cluster and SBS kit. Exomes were sequenced to an average coverage of ×139 with 98% of targeted bases covered with at least ×20. Mutations were analyzed and validated by comparing with 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project and 1000genome project by WuXi NextCODE (Shanghai, China). The presence of c.4140-4142delCAA (p.N1380del) in the SCN5A gene, initially identified by whole exome sequencing, was assessed in other family members by Sanger sequencing. Exon 23 was amplified by nested-polymerase chain reaction using primer pairs: In-F, 5′-TTTGGGCACTGTGATCCTCC-3′, In-R, 5′-GCAGCCAGGGAG TTCATTCT-3′, Out-F, 5′-TCCCAAGGAGCCAAATCCC-3′, and Out-R, 5′-GGCCAAGAAGGGAAACCAGA-3′.
Site-directed mutagenesis
The pcDNA3.1-WT-SCN5A plasmid expressing human wild-type SCN5A was provided by Dr Shiqing Cai (Institute of Neuroscience and State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Science, Shanghai, China). The mutation N1380del was obtained by site-directed mutagenesis using primer pair: Mut-F, 5′-CTACACCATCGTGAACAAGAGCC AGTGTGAGT-3′, and Mut-R, 5′-CACACTGGCTCTTGTTCAC GATGGTGTAGTTC-3′. Both wild-type and mutant plasmids were verified by sequencing performed by the Shanghai RuiDi Biological Technology Co (Shanghai, China).
Biophysical analysis of SCN5A mutation
Human HEK293T cells were transfected with Lipofectamine™ 2000 (Invitrogen, Carlsbad, USA) according to manufacturer's instructions. For patch-clamp recordings, HEK293T cells were transfected with 1 μg pcDNA3.1-WT-SCN5A or 1 μg pcDNA3.1-N1380del-SCN5A together with 0.5 μg plasmids expressing green fluorescent protein as a reporter gene. To mimic the heterozygous state in patients, cells were co-transfected with 0.5 μg pcDNA3.1-WT-SCN5A and 0.5 μg pcDNA3.1-N1380del-SCN5A. Twenty-four hours after transfection, the resulting sodium current (I Na ) was recorded at room temperature (23-25°C) under whole-cell voltage clamp conditions with an Axopatch 200B (Axon Instruments Inc., Foster City, USA) amplifier interfaced to computer and driven by the PClamp 10 software (Molecular Devices Corporation, Sunnyvale, USA). The extracellular bath solution contained 147 mM NaCl, 4 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM Piperazineethanesulfonic acid (HEPES), and 10 mM D-glucose (pH 7.4 adjusted with NaOH). A glass recording pipette was filled with 105 mM CsF, 35 mM NaCl, 10 mM HEPES, and 10 mM EGTA (pH 7.4 adjusted with CsOH). Capacitance and series resistances were compensated (60-80% compensation).
Statistical analysis
Results are presented as the mean ± SEM. Single comparison between two groups was performed with unpaired 2-tailed Student's t-test. Statistical significance was obtained when P < 0.05.
Results
Clinical presentations
The proband, a 14-year-old boy, was admitted to Zhongshan Hospital in August 2015. He suffered from syncope twice prior to admission. He was 154 cm in height and 45 kg in weight. The result of 12-lead ECG showed sinus rhythm, Type II second degree sinoatrial block, first-degree atrioventricular block (AVB), intraventricular conduction disturbance, and T-wave inversion in leads V3-4. Holter was performed after admission. Type II second degree sinoatrial block, junctional rhythm at night, frequent multifocal ventricular premature beats, and paroxysmal ventricular tachycardia were revealed (Fig. 1A,B) . No structural abnormalities were seen in echocardiography and cardiac MRI. Left ventricular ejection fraction was 62% in echo and 56.2% in MRI report. Bundle branch re-entrant ventricular tachycardia was diagnosed during intracardiac electrophysiology studies (Fig. 1C) and right bundle branch was blocked by application of radiofrequency ablation energy. Meanwhile, a conduction disturbance at and under His bundle was revealed with prolonged His-ventricular (HV) interval (84 ms) and widened H wave (40 ms). Transcatheter endomyocardial biopsy was performed and no abnormalities were found in pathological examination including hematoxylin-eosin, masson, and Congo red staining (Fig. 2) . Because of the limited finances, a VVI pacemaker was implanted and drug therapy with oral sotalol hydrochloride 40 mg bid was instituted. No syncope recurred during follow-up up to April 2016.
Whole exome sequencing results
The whole exome sequencing analysis revealed an in-frame deletion mutation p.N1380del on exon 23 in the SCN5A gene. This deletion results in the removal of a highly conserved asparagine amino acid at position 1380 in the SCN5A protein (Fig. 3) . The variant is absent in the unaffected mother.
Family history and genotype test
The family has a paternal history of sudden unexpected nocturnal death (Fig. 4A) . The proband's father (II 2) died at the age of 42 in his sleep. The proband has three uncles, one of them (II 8) died at the age of 20 in his sleep, and another one (II 1) died suddenly at the age of 8. The only living uncle (II 6) was an asymptomatic mutation carrier, and first-degree AVB was revealed in 12-lead ECG with normal echocardiography (Fig. 4B) . The proband's aunt (II 4) and mother (II 3) were asymptomatic with normal clinical evaluations and did not carry the mutation. The proband had two sisters Bundle branch re-entrant ventricular tachycardia was diagnosed according to the following observations: the QRS morphology during tachycardia was almost identical to that during atrial pacing; each QRS was preceded by a His deflection; the HV interval during tachycardia was longer than that during atrial pacing or junctional rhythm; changes in V-V interval were predicted by similar changes in H-H interval; right bundle branch ablation abolished further induction of the clinical VT. ECG, electrocardiography, AVB, atrioventricular block.
(III1 21 years old and III3 13 years old) (Fig. 4C,D) who were asymptomatic mutation carriers; 12-lead ECG revealed nonspecific intraventricular conduction disturbance according to the diagnosis standard [10] . The living uncle's daughter (III7) was also an asymptomatic mutation carrier with a normal ECG.
Whole-cell patch clamping
Electrophysiology study in HEK293T cells suggested that the N1380del mutation resulted in a loss of detectable Na + channel current. Cells were clamped at a holding potential of −120 mV and subject to 500 ms duration depolarization pulses between −120 and +50 mV in 10 mV increments at pulse frequency of 10 Hz. HEK293T cells were transiently transfected with plasmid DNA of either pcDNA3.1-SCN5A-WT or pcDNA3.1-N1380del-SCN5A. The wholecell configuration of the patch-clamp technique was used. Results showed that Na + current, I Na , recorded from the HEK293T cells transfected with plasmid for pcDNA3.1-WT-hNa v 1.5 showed average peak current densities of −52.65 ± 16.24 (pA/pF, cell = 7), whereas cells transfected with pcDNA3.1-N1380del-hNa v 1.5 did not show any detectable I Na . In the heterozygous state (equal amount of wild-type and mutant plasmids were transfected), no detectable I Na was recorded in HEK293T cells (Fig. 5) .
Discussion
In the present study, a SCN5A mutation was found in a Chinese family with sudden unexpected nocturnal death. The proband revealed a clinical manifestation as ventricular tachycardia, cardiac conduction defect, including sinus node, atrioventricular node, and His bundle.
SCN5A plays a key role in the maintenance of impulse conduction in cardiomyocytes. Our study showed a correlation between clinical manifestation and biophysical characterization of the mutation. The same mutation N1380del has been reported to be associated with BrS in 81st Annual Scientific Session of the American-HeartAssociation [11] . It has not been identified by Exome Aggregation Consortium (http://exac.broadinstitute.org/gene/ENSG00000183873, 13 January 2017, date last accessed). It was not found in~6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project or 1000genome Project, indicating that it is not a common variant in these populations. Missense mutations in this same residue [12] (N1380K) and in nearby residues [13] (V1378M) have been reported in association with BrS, supporting the functional importance of this residue and this region. In contrast to other reports, the mutation in the present study resulted in a mixed clinical syndrome characterized by SSS, PCCD, and ventricular tachycardia (VT). Many studies have revealed that some mutations of SCN5A may cause overlap syndrome with multiple clinical phenotypes [14] [15] [16] [17] [18] [19] . Furthermore, the same mutation in different patients may cause different clinical manifestations [20] . As exemplified by the family in the present study, the clinical phenotype and onset time of mutation carriers differs. The mechanism remains unclear. One possible explanation may be that many factors contribute to the modification and regulation of sodium channel function including β subunits, Ca 2+ /calmodulin-dependent protein kinase II [21] , ankyrin-G [22] , and ubiquitinproteasome system [23] . These factors, together with environmental factors, may influence the occurrence of the clinical phenotype.
The five family members who proved to be mutation carriers through genetic analysis showed different ECG phenotypes of conduction defect. Consisting with Brugada characteristic, two of the three males suffered from sudden unexpected death in this family happened nocturnally. BrS is characterized by an ST-segment elevation in the right precordial leads (V1-3) on surface ECG and sudden unexpected nocturnal death. However, no typical Brugada ECGs were recorded in the proband and other mutation carriers. The BrS was reported to have a low penetrance, with over 80% of pathogenic mutation carriers having a normal ECG phenotype [24] . A flecainide challenge test could be considered for further diagnosis on mutation carriers.
The structure of human voltage-gated sodium channel Type 5 includes four repetitive transmembrane domains (DI-DIV). Each domain consists of six transmembrane spanning sections (S1-S6). The four S5-S6 sections and intervening loop domains are the central pore-forming region of Nav1.5 which plays a crucial role in ion selectivity and permeation. The mutation found in this study was located in the intervening loop domains of S5 and S6 in DIII. Many mutations, including G1406R [20] , and R878C [25] among others, have been reported in the pore-forming region. Among them, several mutations including G1406R, R878C, and R1432G [26] did not show any detectable I Na in transfected cells, as was the case for N1380del mutation in the present study. Cell electrophysiology studies of these mutations revealed a loss of function sodium channel. In general, SCN5A mutations leading to a decrease in I Na (lossof-function) have been associated with conduction defect, BrS, and sick sinus node. Gain-of-function mutations of SCN5A mainly caused typical LQT3. The clinical phenotype of N1380del therefore is consistent with previous researches.
The mutation may influence the membrane expression of the channel by changing the protein structure, misfolding, and retention in the endoplasmic reticulum (ER). Besides the dysfunction of channels in the cellular membrane, the decrease of current density can also be caused by membrane expression defect of channel protein.
The reduction in the current densities of V1378M mutation channels was caused by their retention in the ER [13] . The mechanism of N1380del mutation may be similar, and warrants further study. In the present study, to mimic the heterozygous state in proband, equal amount of wild-type and mutant plasmids were co-transfected into HEK293T cells, but no detectable I Na could be recorded, indicating a dominant-negative effect of p.N1380del SCN5A mutant. Dominant-negative effect means that the mutant protein negatively interferes with the co-expressed wild-type protein and reduces its cellular function. Previous studies have demonstrated the dominantnegative effect of mutant in voltage-gated sodium channels [27] , including K + , Ca
2+
, and Na + [28, 29] channels. The mechanism of dominant-negative effect in Na v 1.5 remains unclear, and the direct and indirect interactions between mutant and normal protein may influence the folding, trafficking [29] , and glycosylation [30] of Nav1.5 function.
In the family studied, the clinical phenotype was characterized by male predominance. Family members who suffered sudden unexpected death and severe arrhythmia were all male. A similar male predominance was seen in BrS [31] and familial sick sinus syndrome caused by SCN5A mutations. Different sex hormones may impact cardiac electrophysiology, especially upon cardiac repolarization [32] , and underlie gender predominance. Gender differences may make contributions to genetic factors effecting clinical phenotype.
In summary, we have identified a SCN5A mutation N1380del which can lead to cardiac conduction defect and bundle branch turnback ventricular tachycardia. Cells transfected with pcDNA3.1-N1380del-SCN5A did not show any detectable I Na , suggesting a loss of function of sodium channel.
